and (ii) proliferative astrogliosis, which is anisomorphic with loss of domain, substantial structural reorganisation and can either be diffuse or can result in the formation of new compact limitans borders around overt fibrotic tissue lesions (Fig
DSIP may be the answer youve been looking for
While more large-scale, double-blind clinical trials are currently underway to map the exact pharmacokinetics of new liposomal formulations, the existing body of evidence strongly supports the use of Liposomal Glutathione as a foundational, science-backed intervention for repairing mitochondrial damage, supporting liver detoxification, and restoring cellular homeostasis in complex chronic illness
For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance